In the original publication [1], there was a mistake in Figure 2 as published. The cited article (ref. [208], regarding miR-34a) was retracted after the publication of the present review; therefore, Figure 2 was no longer accurate. The corrected Figure 2 appears below.
In addition to reference [208], an error was found in reference [33]. Both references were removed, citation in Section 1, together with the related text in Section 3. Extracellular Vesicles as Nano Mediators in Glioblastoma Progression, Sub-section 3.2. Extracellular Vesicles and Their Associated microRNAs as Protagonists in Glioblastoma Progression, Paragraph Number 3, and Section 4. Therapeutic Potential of microRNA-Carrying Extracellular Vesicles against Glioblastoma, Sub-section 4.2. Extracellular Vesicles as Therapeutic Tools in Glioblastoma Treatment, Paragraph Number 3.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Simionescu N., Zonda R., Petrovici A.R., Georgescu A. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. Pharmaceutics. 2021;13:988. doi: 10.3390/pharmaceutics13070988. [DOI] [PMC free article] [PubMed] [Google Scholar]